AROMA

A Randomised trial to Optimise outcomes in patients with multiple or large brain Metastases

The most effective treatment for patients with brain metastases has traditionally been considered to be surgery or stereotactic radiotherapy. However, most patients with brain metastases are not suitable for surgery or SRS, and receive whole-brain radiotherapy. AROMA is a randomised trial exploring the benefits of modern types of radiotherapy to treat patients with brain metastases who would normally have whole-brain radiotherapy, with the aim of improving quality of life and survival.

AROMA: About

PUBLISHED WORK

IMPROVING ON WHOLE-BRAIN RADIOTHERAPY IN PATIENTS WITH LARGE BRAIN METASTASES: A PLANNING STUDY TO SUPPORT THE AROMA CLINICAL TRIAL

February 2022

Jiarong Chen, Georges Sinclair, Hamoun Rozati, Laurence Hill, Lillie Pakzad-Shahabi, James Wang, Kerlann Le Calvez, Ian Paddick, Matt Williams